Press Release Source: Guided Therapeutics, Inc. On Friday June 11, 2010, 10:52 am EDT
NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCBB: GTHP) today announced that its stock is now trading on the OTCBB under the symbol GTHP, following approval of the listing by the Financial Industry Regulatory Authority (FINRA).
“Listing our stock on the OTCBB is an important milestone for the company as we continue to build value for our shareholders,” said Mark L. Faupel, Ph.D., chief executive officer and president of Guided Therapeutics. “The listing is one in a series of recent positive events for the company that includes significantly reducing our debt, strengthening our board of directors, simplifying our capital structure and maintaining current filer status with the Securities and Exchange Commission.”
About Guided Therapeutics
Guided Therapeutics, Inc. (OTCBB: GTHP) is developing a rapid and painless test for the early detection of disease that leads to cervical cancer. The technology is designed to provide an objective result at the point of care thereby improving the management of cervical disease. Unlike Pap and HPV tests, the device does not require a painful tissue sample and results are known immediately. GT has also entered into a partnership with Konica Minolta Opto to develop a non-invasive test for Barrett’s Esophagus using the LightTouch™ technology platform. For more information, visit GT’s web site www.guidedinc.com.
The Guided Therapeutics LightTouch™ Cervical Scanner is an investigational device and is limited by federal law to investigational use. |
